New experiments suggest the famous tumor-suppressing protein uses viral elements lingering in the genome to get cancerous cells to announce their presence to the immune system.

It’s now thought that in many cases, cancer cells disseminate from the primary tumor site early on and lay dormant for long periods rather than only venturing out from primary tumors at an advanced stage.

Recent insights, such as the recognition that disseminated cancer cells can lie dormant for years before seeding secondary tumors, suggest novel strategies for fighting metastatic disease.

When tumor cells are infected with an oncolytic virus carrying a modified CD19 gene, they become targets for CAR T cells engineered to recognize this molecular marker.

A study suggests the potential for a noninvasive diagnostic that could detect tumors early and differentiate between disease types.

Spurred by family tragedy, the medical physicist wants to treat cancer in a new way.

Injecting the seasonal flu vaccine directly into clumps of malignant cells recruits immune cells to confront the cancer.

Researchers use a cutting-edge technique to map the blood vessels of brain tumors as patients are awake during surgery with the hope of reducing damage to adjacent tissues.

Three-dimensional tissue cultures grown from cancer patients’ own tumors can predict responses to the drug irinotecan.

Three studies show that tumor cells can behave like neurons.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

The Michigan State University researcher’s lab experiences shaped her interest in the role of glucose in cancer’s spread.

Researchers have developed a prototype device to filter excess chemotherapy medication from the bloodstream.